A recent publication in Drug Discovery Today by pulmocide scientists provides an in depth review on current approaches to the discovery of new treatments which are administered by the inhaled […]
Pulmocide presented two posters at the recent 8th Advances Against Aspergillosis Conference, held February 1-3, 2018 in Lisbon, Portugal. There are as follow A full copy of the scientific posters […]
16 February 2018
Pulmocide and PGIMER (Chandigarh, India) presented one poster at the recent 8th Trends in Medical Mycology Conference, held November 6-9, 2017 in Belgrade, Serbia. There are as follow A full […]
16 February 2018
Pulmocide today announces the successful dosing PC945 in a phase 1 study. PC945 is a novel antifungal agent which is delivered by inhaled administration for the treatment of Aspergillus Fumigatus […]
21 November 2017
Pulmocide is pleased to announce another PC945 publication in Antimicrobial Agents and Chemotherapy. The publication is available to download from the link below: AAC.ASM.ORG or the PDF can be downloaded […]
03 July 2017
Pulmocide gave an oral presentation at Annual Conference of Microbiology society 2017, held on April 02-06, 2017 in Edinburgh in UK. Title was: Preclinical characterization of PC786, a novel inhaled […]
26 April 2017
Pulmocide is pleased to announce a PC945 publication in Antimicrobial Agents and Chemotherapy. The Publication is available to download from the link below Download or can be found online at […]
26 April 2017
Funding to progress novel wholly-owned compounds for RSV and pulmonary Aspergillosis London, UK, 20 March 2017: Pulmocide Ltd, the UK-based drug discovery company developing novel compounds designed for inhaled […]
20 March 2017
Pulmocide presented two posters at the IDweek 2016, held October 26 – 30, 2016 in New Orleans, LA. These are as follows: Anti-viral activities of PC786, a novel inhibitor […]
08 November 2016
Pulmocide gave an oral presentation (as a late breaking abstract) at European respiratory society annual meeting 2016, held September 03 – 07, 2016 in London, UK. This is as follows: […]
04 October 2016